Holen Sie sich die Stockscreener-App
88.72
0.80%
-0.625
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$89.34
Offen:
$88.6
24-Stunden-Volumen:
326.20K
Relative Volume:
0.10
Marktkapitalisierung:
$35.80B
Einnahmen:
$4.03B
Nettoeinkommen (Verlust:
$576.20M
KGV:
62.04
EPS:
1.43
Netto-Cashflow:
$630.70M
1W Leistung:
-0.50%
1M Leistung:
+2.67%
6M Leistung:
+21.08%
1J Leistung:
-23.85%
1-Tages-Spanne:
$87.56
$89.17
1-Wochen-Bereich:
$87.56
$93.25
52-Wochen-Spanne:
$62.34
$142.00
Dexcom Inc Stock (DXCM) Company Profile
Firmenname
Dexcom Inc
Sektor
Branche
Telefon
(858) 200-0200
Adresse
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Vergleichen Sie DXCM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
88.65 | 35.80B | 4.03B | 576.20M | 630.70M | 1.43 |
|
ABT
Abbott Laboratories
|
134.38 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.43 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
386.55 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.82 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.12 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-03 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-03-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2023-01-26 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-15 | Eingeleitet | Bernstein | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-03 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-10-18 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-28 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-01-06 | Hochstufung | UBS | Neutral → Buy |
| 2020-10-02 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-11-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-11-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-10-23 | Eingeleitet | Stifel | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-10-19 | Hochstufung | Goldman | Sell → Neutral |
| 2018-09-12 | Hochstufung | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Bestätigt | Canaccord Genuity | Buy |
| 2018-07-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Eingeleitet | BofA/Merrill | Buy |
| 2018-05-03 | Bestätigt | Canaccord Genuity | Buy |
| 2018-04-04 | Eingeleitet | Goldman | Sell |
| 2018-04-04 | Eingeleitet | Guggenheim | Neutral |
| 2018-03-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Herabstufung | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Bestätigt | Wedbush | Outperform |
Alle ansehen
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
Glucose Biosensor Market to Witness Remarkable Growth with Abbott Laboratories, Dexcom, F. Hoffmann-La Roche - EIN News
Earnings Miss: DexCom, Inc. Missed EPS By 7.8% And Analysts Are Revising Their Forecasts - Simply Wall St
Ownership Capital B.V. Decreases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Principal Financial Group Inc. Decreases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Peregrine Capital Management LLC Sells 29,135 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Lost Money on DexCom, Inc.(DXCM)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire
Alberta Investment Management Corp Acquires 36,500 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Lyell Wealth Management LP Has $4.71 Million Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Congress Asset Management Co. Increases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by GAM Holding AG - MarketBeat
Kornitzer Capital Management Inc. KS Has $4.34 Million Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Chevy Chase Trust Holdings LLC Sells 9,886 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Leerink Partnrs Has Bullish Forecast for DexCom Q1 Earnings - MarketBeat
Morgan Stanley Issues Positive Forecast for DexCom (NASDAQ:DXCM) Stock Price - MarketBeat
Is DexCom, Inc. (DXCM) the Best IoT Stock to Buy According to Analysts? - Insider Monkey
Cardinal Capital Management Invests $3.46 Million in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Van ECK Associates Corp Increases Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Banque Pictet & Cie SA Acquires 14,419 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Kestra Private Wealth Services LLC Grows Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Position Lessened by Compagnie Lombard Odier SCmA - MarketBeat
DexCom (NASDAQ:DXCM) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
DexCom's SWOT analysis: stock faces challenges amid growth potential - Investing.com India
Baillie Gifford & Co. Has $1.14 Billion Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Rhumbline Advisers Reduces Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Vontobel Holding Ltd. Trims Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Louisiana State Employees Retirement System Sells 3,700 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for DexCom (NASDAQ:DXCM) Stock - MarketBeat
Empire Life Investments Inc. Raises Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
New York State Teachers Retirement System Cuts Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Asset Management One Co. Ltd. Has $19.53 Million Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Q4 2024 Earnings Call Transcript - MSN
DexCom Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
3,145 Shares in DexCom, Inc. (NASDAQ:DXCM) Acquired by Angeles Wealth Management LLC - MarketBeat
Equitable Trust Co. Has $925,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Savant Capital LLC Has $8.58 Million Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom’s Optimistic Earnings Call: Growth Amid Challenges - TipRanks
DexCom Inc. stock outperforms competitors on strong trading day - MSN
DexCom (NASDAQ:DXCM) Stock Quotes, Forecast and News Summary - Benzinga
DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationDXCM - ACCESS Newswire
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom - Benzinga
Meta Platforms, Dexcom, Dell - TradingView
DexCom Unusual Options Activity - Benzinga
DexCom, Inc.'s (NASDAQ:DXCM) Intrinsic Value Is Potentially 38% Above Its Share Price - Simply Wall St
DexCom stock target raised to $100 by Bernstein analysts - Investing.com Nigeria
DexCom Likely to Sustain Stability in 2025, Morgan Stanley Says -February 14, 2025 at 12:12 pm EST - Marketscreener.com
DexCom Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart
DexCom Analysts Increase Their Forecasts After Q4 Earnings - Benzinga
Piper Sandler Adjusts Price Target on DexCom to $100 From $90 -February 14, 2025 at 08:45 am EST - Marketscreener.com
Wells Fargo Adjusts Price Target on DexCom to $98 From $94 -February 14, 2025 at 08:45 am EST - Marketscreener.com
Citigroup Adjusts Price Target on DexCom to $101 From $91 -February 14, 2025 at 08:37 am EST - Marketscreener.com
Bernstein Adjusts Price Target on DexCom to $100 From $89 -February 14, 2025 at 08:33 am EST - Marketscreener.com
Finanzdaten der Dexcom Inc-Aktie (DXCM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.89%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):